The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Evsutina Yu.V.

National Research Center for Preventive Medicine of the Ministry of Healthcare of the Russia, Moscow, Russia

Drapkina O.M.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova, Klinika propedevtiki vnutrennikh bolezneĭ, gastroénterologii i gepatologii

The most effective colorectal cancer screening strategies

Authors:

Evsutina Yu.V., Drapkina O.M.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2019;22(1): 105‑108

DOI: 10.17116/profmed201922011105

Views: 3114

Downloaded: 170

Download PDF (RU)
Contact the author
Table of contents

THE MOST EFFECTIVE COLORECTAL CANCER SCREENING STRATEGIES
THE MOST EFFECTIVE COLORECTAL CANCER SCREENING STRATEGIES

To cite this article:

Evsutina YuV, Drapkina OM. The most effective colorectal cancer screening strategies. Russian Journal of Preventive Medicine. 2019;22(1):105‑108. (In Russ.)
https://doi.org/10.17116/profmed201922011105

 
Подписка 2025-2 (Russian Journal of Preventive Medicine)
 
МСФ на ЯМ
Close metadata

Colorectal cancer (CRC) dominates in the structure of cancer morbidity and mortality. In most countries, including in Russia, the number of new cases of CRC continues to grow and can reach 2.2 million by 2030. Numerous studies and metaanalyses have shown that screening for CRC is an efficient and cost-effective technique to detect the early forms of the disease and to reduce death rates. The review presents various methods for screening for CRC and international and Russian clinical guidelines for its prevention.

Keywords:

colorectal cancer
adenoma
screening
colonoscopy
fecal immunochemical test

Authors:

Evsutina Yu.V.

National Research Center for Preventive Medicine of the Ministry of Healthcare of the Russia, Moscow, Russia

Drapkina O.M.

Pervyĭ Moskovskiĭ gosudarstvennyĭ meditsinskiĭ universitet im. I.M. Sechenova, Klinika propedevtiki vnutrennikh bolezneĭ, gastroénterologii i gepatologii

List of references:

  1. Ferlay J, Soerjomataram I, Dikshit R, et al. Eser SCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-E386. https://doi.org/10.1002/ijc.29210
  2. Vsemirnaya organizatsiya zdravookhraneniya. Profili raka v stranakh. 2014. https://www.who.int/cancer/country-profiles/ru/
  3. Laiyemo AO, Murphy G, Albert PS, et al. Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years. Ann Intern Med. 2008;148:419. https://doi.org/10.7326/0003-4819-148-6-200803180-00004
  4. Bray F. Transitions in human development and the global cancer burden. In: Steward BW, Wild CP, eds. World Cancer Report 2014. Lyon: International Agency for Research on Cancer, 2014;54-68.
  5. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology. 2003;124:544-560. https://doi.org/10.1053/gast.2003.50044
  6. Guittet L, Bouvier V, Mariotte N, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut. 2007;56:210-214. https://doi.org/10.1136/gut.2006.101428
  7. Robertson DJ, Lee JK, Boland CR, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastroenterology. 2017;152(5):1217-1237.e3. https://doi.org/10.1053/j.gastro.2016.08.053
  8. Weinberg DS, Barkun A, Turner BJ. Colorectal Cancer Screening in the United States: What Is the Best FIT? Ann Intern Med. 2017;166:297-298. https://doi.org/10.7326/M16-2341
  9. Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012;366:697-706. https://doi.org/10.1056/NEJMoa1108895
  10. Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370:1287-1297. https://doi.org/10.1056/NEJMoa1311194
  11. Holme Ø, Schoen RE, Senore C, et al. Effectiveness of flexible sigmoidoscopy screening in men and women and different age groups: pooled analysis of randomised trials. BMJ. 2017;356:i6673. https://doi.org/10.1136/bmj.i6673
  12. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med. 2009;150:1-8.
  13. Rex DK, Boland CR, Dominitz JA, et al. Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017;112(7):1016-1030. https://doi.org/10.1038/ajg.2017.174
  14. Ladas SD, Triantafyllou K, Spada C, et al. European Society of Gastrointestinal Endoscopy (ESGE): recommendations (2009) on clinical use of video capsule endoscopy to investigate small-bowel, esophageal and colonic diseases. Endoscopy. 2010;42:220-227. https://doi.org/10.1055/s-0029-1243968
  15. Enns RA, Hookey L, Armstrong D, et al. Clinical Practice Guidelines for the Use of Video Capsule Endoscopy. Gastroenterology. 2017;152:497-514. https://doi.org/10.1053/j.gastro.2016.12.032
  16. Zauber AG. Cost-effectiveness of colonoscopy. Gastrointest Endosc Clin N Am. 2010;20:751-770. https://doi.org/10.1016/j.giec.2010.07.008
  17. Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of Colorectal Cancer Screening. Epidemiol Rev. 2011;33(1):88-100. https://doi.org/10.1093/epirev/mxr004
  18. Patel SS, Kilgore ML. Cost Effectiveness of Colorectal Cancer Screening Strategies. Cancer Control. 2015;22(2):248-258. https://doi.org/10.1177/107327481502200219
  19. US Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2016;315:2564. https://doi.org/10.1001/jama.2016.5989
  20. American Cancer Society Guideline for Colorectal Cancer Screening https://www.cancer.org/cancer/colon-rectal-cancer/detection-diagnosis-staging/acs-recommendations.html
  21. Wilkins T, Mcmechan D, Talukder A. Colorectal Cancer Screening and Prevention Am Fam Physician. 2018;97(10):658-665.
  22. Wilt TJ, Harris RP, Qaseem A, High Value Care Task Force of the American College of Physicians. Screening for cancer: advice for high-value care from the American College of Physicians. Ann Intern Med. 2015;162:718-725. https://doi.org/10.7326/M14-2326
  23. Canadian Task Force on Preventive Health Care, Bacchus CM, Dunfield L, et al. Recommendations on screening for colorectal cancer in primary care. CMAJ. 2016;188:340-348. https://doi.org/10.1503/cmaj.151125
  24. https://www.swisscancerscreening.ch/fr/offres-dans-votre-canton/programmes-cantonaux-cancer-du-sein/vaud/depistage-du-cancer-du-colon/le-depistage-du-cancer-du-colon-en-pratique
  25. Ponti A, Anttila A, Ronco G, et al. Cancer Screening in the European Union. Report on the implementation of the Council Recommendation on cancer screening. 2017.
  26. Prikaz Ministerstva zdravookhraneniya RF №869n ot 26.10.17 «Ob utverzhdenii poryadka provedeniya dispanserizatsii opredelennykh grupp vzroslogo naseleniya». https://static-rosminzdrav.ru/system/attachments/attaches/000/037/745/original/Приказ_Минздрава_России_от_26_октября_2017_г._№_869н_Диспансеризация.pdf?1520866749
  27. Moreira L, Balaguer F, Lindor N, et al. Identification of Lynch syndrome among patients with colorectal cancer. JAMA. 2012;308:1555-1565. https://doi.org/10.1001/jama.2012.13088
  28. Vasen HF, Tomlinson I, Castells A. Clinical management of hereditary colorectal cancer syndromes. Nat Rev Gastroenterol Hepatol. 2015;12:88-97. https://doi.org/10.1038/nrgastro.2014.229
  29. Provenzale D, Gupta S, Ahnen DJ, et al. Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14:1010-1030.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.